Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00495599 · ClinicalTrials.gov registry record · Phase 3
Adipose Secretory Function in Patients Before & After Laparoscopic Surgery
A Phase 3 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 3
- Development phase
- 107
- Enrollment target
NCT00495599 is a Phase 3 study that has completed, run by Vanderbilt University. The registered enrollment target is 107 participants.
The verdict
NCT00495599, a Phase 3 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 107 participants
- Enrollment target
Study Summary
The central hypothesis of our study is that metabolic and hemodynamic improvements following gastric bypass surgery are mediated by downregulation of inflammation-related adipokines produced by the intra-abdominal adipose tissue such as Visfatin.
Interventions
- PROCEDURE Cytokines assessed from fat tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00495599
The ClinicalTrials.gov registry entry for NCT00495599 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cytokines assessed from fat tissue is the first listed.
NCT00495599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00495599 about?
NCT00495599 is a clinical study titled "Adipose Secretory Function in Patients Before & After Laparoscopic Surgery". The central hypothesis of our study is that metabolic and hemodynamic improvements following gastric bypass surgery are mediated by downregulation of inflammation-related adipokines produced by the intra-abdominal adipose tissue such as Visfatin.
What is the current status of trial NCT00495599?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 107 participants. The study started on 2006-03. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00495599?
The interventions under investigation include: Cytokines assessed from fat tissue (PROCEDURE).
Who is sponsoring clinical trial NCT00495599?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.